PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Morgan Goodwin is a UK-based company that pioneers the Combined Trading Platform (CTP) category, offering a comprehensive online platform for small businesses engaged in physical goods trading, along with specialized software development services, and a broad-spectrum business consultancy approach aimed at enhancing growth, efficiency, and technological advancement.
days to go:
Stretch
investment:
£788,519
Doqit offers a solution for managing life admin tasks, helping you organize important information, set action dates, and receive timely reminders, ultimately streamlining tasks like insurance renewals and warranties to reduce unnecessary expenses and simplify your life. It provides secure storage and easy access for vital information, transitioning from chaos to simplicity.
Security is also a priority for Doqit. The platform ensures that your sensitive information is stored securely, giving you peace of mind knowing that you can access your important documents and data whenever you need them, all within a few clicks.
days to go:
Extended
investment:
£87,500
UTU is a company dedicated to building the trust infrastructure for the evolving web 3.0. They aim to facilitate safer and more reliable interactions between users and platforms by utilizing a decentralized reputation and reviews protocol. This protocol involves a non-tradable reputation token (UTT) that users can stake to endorse others, leading to positive outcomes. UTU's focus initially lies in Web3 and DeFi apps, where they provide AI-powered tools to curate trust signals and help users engage confidently in various online activities. They offer a range of products, including the UTU Trust Token, Browser Extension, and Trust API/SDK, all aimed at enhancing trust and security in digital interactions.
days to go:
Extended
investment:
£150,000
Snoop is an application that aims to save a user's money by using data analytics. Snoop falls under the Financial Conduct Authority's (FCA) regulated Open Banking technology. The company asserts that Snoop can help every household in the UK save at least £1,500 each year. The app lets a user connect his/her bank accounts and credit cards to Snoop to observe all the balances and transactions together from a single portal. Snoop also watches a user's bills and lets the user know if he/she is paying too much or if there’s a price hike. The app also creates a 100% personalised feed of money-saving ideas based on the user's spending patterns. Snoop has grown to over 100,000 downloads and 75,000 customers since early 2020, delivered over 1 million money management tips to customers, and featured in publications like The Guardian, Financial Times, and The Telegraph. It will use 57% of the investment to grow its business, 21% to develop app functionality, and 22% for business operations.
days to go:
Expired
investment:
£8,445,740
Darqube is a comprehensive platform for smarter investing. The company aims to equip finance enthusiasts, novice traders, and professionals with financial technology instruments, trading analytics, and algorithmic trading tools to hasten investment decisions. The company has multiple financial products on its platform like forex, mutual funds, cryptocurrency, and bonds. In 2019, the company launched 'Terminal', a comprehensive trading analytics platform. The year 2020 saw the company launch 'TradeLab Beta', an algorithmic trading platform, and 'Messenger', a messaging platform tailored to the needs of finance enthusiasts. Darqube has 5000 monthly active users and 75,000+ community followers. The company has also been featured in prominent publications like Business Insider, Yahoo Finance, and Marketwatch. The company will use 40% of the investment towards growth and user acquisition, 25% for product improvement, 25% for team expansion, and 10% as operating costs.
days to go:
Expired
investment:
£461,811
whatimpact is a social impact technology entity that uses AI and specific reporting tools to match charities and social enterprises, termed 'Recipients', with donor companies and grant-makers, termed 'Supporters' to ensure efficiency and transparency in Corporate Social Responsibility (CSR) and grant-making. whatimpact aspires to become a contender in the CSR segment that is estimated to be worth over £76 billion in reputational value to UK corporates. The business has onboarded 20 companies and 120 charities/Social Enterprises in Q1 2021 including EY, Brewin Dolphin, and Engie. whatimpact has a further 500 charities/social enterprises and 45 corporates in the pipeline. Its subscriptions range from £100/month to £2,000/month. It will use the investment to develop its algorithm and datasets, engage in customer acquisition, and build its leadership team.
days to go:
Expired
investment:
£375,002
Quotall is a specialist insurance technology software entity that helps large, high profile enterprises to enter the insurance market. The company claims that to date, brands have struggled to extend into insurance due to significant up-front costs, regulatory concerns, legacy technology in the insurance sector and a lack of in-house expertise. Quotall claims that its insurance ecosystem service aims to remove these barriers and enable rapid market entry. The company asserts that it can arrange regulatory approval for the client and link the latter's customers through to its fully client-branded, quote, buy and self-service insurance platform. Quotall's earned revenues in 2020 reached close to £500,000 and it has raised £4 million to date. It states it will use the investment to resource the implementation, development, and servicing of new client accounts as they are contracted.
days to go:
Expired
investment:
£708,805
